We knew the imminent future of the MARS Maryland 5 Star was in jeopardy early this year (and really, if you had an ear to the ...

Barclays 28th Annual Global Healthcare Conference March 11, 2026 1:00 PM EDTCompany ParticipantsKevin Moran - Vice ...

The consensus fair value estimate for Theravance Biopharma has shifted from about US$26.71 to roughly US$15.83 per share, a cut of around 40% that resets expectations around what the stock might be ...

Recessions and other economic shocks are inevitable. Although the timing and particulars of the next downturn or emergency are hard to anticipate, one can predict with certainty that another will ...

Earnings call Bird Construction ended 2025 with a record CAD 11 billion backlog (up 45% YoY), stable revenue at CAD 3.4 billion, and improved adjusted EBITDA margin of 6.5%. Management guides to ...

In this article, we will take a look at the Dividend Kings List: Top 15 Stocks. Dividend Kings are a small group of companies that have raised their dividends for at least 50 consecutive years. Stocks ...

Welcome back to the Barclays Global Healthcare Conference. My name is Andrew Mok. I'm the facilities and managed care analyst here at Barclays. And pleased to welcome on stage Surgery Partners' CEO, ...

Imaging-based single-cell physiological profiling holds great potential for uncovering fundamental bacterial cold shock response (CSR) mechanisms, but its application is impeded by severe focus drift ...